Clene Long Term Debt vs Deferred Long Term Liab Analysis

CLNN Stock

USD 3.88 0.20 4.90%

Clene financial indicator trend analysis is way more than just evaluating Clene Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Clene Inc is a good investment. Please check the relationship between Clene Long Term Debt and its Deferred Long Term Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clene Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Long Term Debt vs Deferred Long Term Liab

Long Term Debt vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Clene Inc Long Term Debt account and Deferred Long Term Liab. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Clene's Long Term Debt and Deferred Long Term Liab is 0.87. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of Clene Inc, assuming nothing else is changed. The correlation between historical values of Clene's Long Term Debt and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Clene Inc are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Long Term Debt i.e., Clene's Long Term Debt and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

0.87

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Long Term Debt

Long-term debt is a debt that Clene Inc has held for over one year. Long-term debt appears on Clene Inc balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Clene Inc balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from Clene's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Clene Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clene Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Clene reported last year Tax Provision of (215,000). As of the 27th of November 2024, Issuance Of Capital Stock is likely to grow to about 56.1 M, while Selling General Administrative is likely to drop about 13.7 M.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	45.7M	45.8M	41.1M	36.4M
Cost Of Revenue	289K	26K	121K	224.2K

Total Operating Expenses Cost Of Revenue

Clene fundamental ratios Correlations

	Other Current Liab	Total Current Liabilities	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Other Stockholder Equity	Total Current Assets	Common Stock	Property Plant Equipment	Total Assets	Short Long Term Debt Total	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Lease Obligations
Other Current Liab		0.5	0.73	0.71	-0.67	0.3	0.63	0.84	-0.66	0.38	0.85	0.39	0.75	0.33	-0.19	-0.6	0.86	0.33	0.77	0.39	0.88	0.77	0.71	-0.79	-0.56	0.39
Total Current Liabilities	0.5		-0.06	0.73	-0.9	0.46	0.76	0.51	-0.06	0.95	0.66	0.74	0.79	0.76	-0.69	0.22	0.41	0.76	0.77	0.51	0.57	0.33	0.79	-0.7	-0.92	0.72
Other Liab	0.73	-0.06		0.16	-0.15	-0.13	0.07	0.42	-0.84	-0.13	0.4	-0.07	0.24	-0.15	0.21	-0.67	0.56	-0.15	0.26	-0.01	0.49	0.58	0.2	-0.3	-0.02	-0.08
Net Tangible Assets	0.71	0.73	0.16		-0.93	0.72	0.96	0.89	-0.33	0.7	0.96	0.85	0.99	0.75	-0.75	-0.19	0.82	0.75	0.99	0.82	0.9	0.62	0.96	-0.99	-0.9	0.85
Retained Earnings	-0.67	-0.9	-0.15	-0.93		-0.68	-0.92	-0.74	0.33	-0.89	-0.88	-0.9	-0.97	-0.86	0.81	-0.03	-0.66	-0.86	-0.96	-0.77	-0.79	-0.49	-0.97	0.93	0.99	-0.89
Accounts Payable	0.3	0.46	-0.13	0.72	-0.68		0.71	0.4	-0.3	0.66	0.56	0.84	0.7	0.87	-0.79	0.31	0.32	0.87	0.72	0.96	0.41	-0.05	0.72	-0.73	-0.72	0.88
Other Stockholder Equity	0.63	0.76	0.07	0.96	-0.92	0.71		0.81	-0.18	0.73	0.89	0.89	0.95	0.82	-0.75	-0.09	0.74	0.83	0.95	0.78	0.81	0.56	0.98	-0.94	-0.9	0.88
Total Current Assets	0.84	0.51	0.42	0.89	-0.74	0.4	0.81		-0.38	0.37	0.96	0.54	0.87	0.39	-0.4	-0.62	0.98	0.39	0.87	0.54	0.99	0.89	0.8	-0.89	-0.65	0.53
Common Stock	-0.66	-0.06	-0.84	-0.33	0.33	-0.3	-0.18	-0.38		-0.12	-0.47	-0.23	-0.41	-0.17	0.18	0.33	-0.48	-0.17	-0.42	-0.41	-0.47	-0.32	-0.34	0.46	0.25	-0.26
Property Plant Equipment	0.38	0.95	-0.13	0.7	-0.89	0.66	0.73	0.37	-0.12		0.57	0.84	0.75	0.9	-0.81	0.44	0.26	0.9	0.74	0.67	0.43	0.09	0.79	-0.68	-0.93	0.84
Total Assets	0.85	0.66	0.4	0.96	-0.88	0.56	0.89	0.96	-0.47	0.57		0.72	0.96	0.59	-0.58	-0.42	0.94	0.59	0.97	0.69	0.98	0.78	0.92	-0.97	-0.81	0.71
Short Long Term Debt Total	0.39	0.74	-0.07	0.85	-0.9	0.84	0.89	0.54	-0.23	0.84	0.72		0.87	0.96	-0.94	0.29	0.46	0.96	0.86	0.9	0.57	0.22	0.9	-0.83	-0.93	1.0
Total Stockholder Equity	0.75	0.79	0.24	0.99	-0.97	0.7	0.95	0.87	-0.41	0.75	0.96	0.87		0.78	-0.77	-0.16	0.81	0.78	1.0	0.81	0.9	0.61	0.97	-0.99	-0.93	0.86
Property Plant And Equipment Net	0.33	0.76	-0.15	0.75	-0.86	0.87	0.82	0.39	-0.17	0.9	0.59	0.96	0.78		-0.89	0.44	0.29	1.0	0.78	0.86	0.43	0.03	0.85	-0.75	-0.9	0.96
Current Deferred Revenue	-0.19	-0.69	0.21	-0.75	0.81	-0.79	-0.75	-0.4	0.18	-0.81	-0.58	-0.94	-0.77	-0.89		-0.43	-0.31	-0.89	-0.74	-0.88	-0.45	-0.08	-0.76	0.7	0.87	-0.95
Net Debt	-0.6	0.22	-0.67	-0.19	-0.03	0.31	-0.09	-0.62	0.33	0.44	-0.42	0.29	-0.16	0.44	-0.43		-0.7	0.44	-0.17	0.2	-0.58	-0.81	-0.08	0.24	-0.17	0.3
Cash	0.86	0.41	0.56	0.82	-0.66	0.32	0.74	0.98	-0.48	0.26	0.94	0.46	0.81	0.29	-0.31	-0.7		0.3	0.81	0.47	0.98	0.92	0.74	-0.84	-0.56	0.45
Non Current Assets Total	0.33	0.76	-0.15	0.75	-0.86	0.87	0.83	0.39	-0.17	0.9	0.59	0.96	0.78	1.0	-0.89	0.44	0.3		0.78	0.86	0.43	0.04	0.85	-0.75	-0.9	0.96
Non Currrent Assets Other	0.77	0.77	0.26	0.99	-0.96	0.72	0.95	0.87	-0.42	0.74	0.97	0.86	1.0	0.78	-0.74	-0.17	0.81	0.78		0.81	0.9	0.61	0.98	-0.99	-0.92	0.86
Long Term Debt	0.39	0.51	-0.01	0.82	-0.77	0.96	0.78	0.54	-0.41	0.67	0.69	0.9	0.81	0.86	-0.88	0.2	0.47	0.86	0.81		0.56	0.13	0.79	-0.82	-0.79	0.94
Cash And Short Term Investments	0.88	0.57	0.49	0.9	-0.79	0.41	0.81	0.99	-0.47	0.43	0.98	0.57	0.9	0.43	-0.45	-0.58	0.98	0.43	0.9	0.56		0.88	0.83	-0.91	-0.7	0.57
Net Receivables	0.77	0.33	0.58	0.62	-0.49	-0.05	0.56	0.89	-0.32	0.09	0.78	0.22	0.61	0.03	-0.08	-0.81	0.92	0.04	0.61	0.13	0.88		0.56	-0.63	-0.37	0.18
Common Stock Total Equity	0.71	0.79	0.2	0.96	-0.97	0.72	0.98	0.8	-0.34	0.79	0.92	0.9	0.97	0.85	-0.76	-0.08	0.74	0.85	0.98	0.79	0.83	0.56		-0.96	-0.93	0.89
Common Stock Shares Outstanding	-0.79	-0.7	-0.3	-0.99	0.93	-0.73	-0.94	-0.89	0.46	-0.68	-0.97	-0.83	-0.99	-0.75	0.7	0.24	-0.84	-0.75	-0.99	-0.82	-0.91	-0.63	-0.96		0.88	-0.84
Non Current Liabilities Total	-0.56	-0.92	-0.02	-0.9	0.99	-0.72	-0.9	-0.65	0.25	-0.93	-0.81	-0.93	-0.93	-0.9	0.87	-0.17	-0.56	-0.9	-0.92	-0.79	-0.7	-0.37	-0.93	0.88		-0.92
Capital Lease Obligations	0.39	0.72	-0.08	0.85	-0.89	0.88	0.88	0.53	-0.26	0.84	0.71	1.0	0.86	0.96	-0.95	0.3	0.45	0.96	0.86	0.94	0.57	0.18	0.89	-0.84	-0.92

Click cells to compare fundamentals

Clene Account Relationship Matchups

Clene fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Current Liabilities	4.3M	11.7M	6.0M	13.9M	25.3M	26.6M
Net Tangible Assets	(67.8M)	341K	12.6M	3.2M	3.7M	3.9M
Retained Earnings	(69.6M)	(153.6M)	(163.3M)	(193.2M)	(242.7M)	(230.6M)
Accounts Payable	889K	1.1M	1.9M	3.0M	1.5M	1.8M
Other Stockholder Equity	(70.9M)	153.6M	175.7M	196.2M	255.9M	130.3M
Total Current Assets	9.5M	63.0M	54.6M	29.2M	38.9M	38.9M
Property Plant Equipment	5.4M	5.3M	5.2M	15.2M	17.5M	18.4M

When determining whether Clene Inc is a strong investment it is important to analyze Clene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clene's future performance. For an informed investment choice regarding Clene Stock, refer to the following important reports:

How To Invest In Clene

Details

Is Clene Stock a good investment?

Details

What is Clene's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clene Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

You can also try the Stocks Directory module to find actively traded stocks across global markets.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clene. If investors know Clene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.614

Earnings Share

(5.29)

Revenue Per Share

0.069

Quarterly Revenue Growth

(0.66)

Return On Assets

(0.42)

The market value of Clene Inc is measured differently than its book value, which is the value of Clene that is recorded on the company's balance sheet. Investors also form their own opinion of Clene's value that differs from its market value or its book value, called intrinsic value, which is Clene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clene's market value can be influenced by many factors that don't directly affect Clene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Clene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Clene Long Term Debt vs Deferred Long Term Liab Analysis

Long Term Debt vs Deferred Long Term Liab

Long Term Debt vs Deferred Long Term Liab Correlation Analysis

Correlation Coefficient

Long Term Debt

Deferred Long Term Liab

Clene fundamental ratios Correlations

Clene Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Clene fundamental ratios Accounts

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Capital Lease Obligations	+ 1.0	Short Long Term Debt Total
Non Currrent Assets Other	+ 1.0	Total Stockholder Equity
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Total Stockholder Equity	+ 0.99	Net Tangible Assets
Non Currrent Assets Other	+ 0.99	Net Tangible Assets
Non Current Liabilities Total	+ 0.99	Retained Earnings

Common Stock Shares Outstanding	- 0.99	Non Currrent Assets Other
Common Stock Shares Outstanding	- 0.99	Total Stockholder Equity
Common Stock Shares Outstanding	- 0.99	Net Tangible Assets
Common Stock Shares Outstanding	- 0.97	Total Assets
Common Stock Total Equity	- 0.97	Retained Earnings
Total Stockholder Equity	- 0.97	Retained Earnings